Atlas Trials

LTX-109 as Treatment for Hidradenitis Suppurativa

Clinical trial NCT04756336 · COMPLETED

Trial details

NCT number
NCT04756336
Sponsor
Pharma Holdings AS
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hidradenitis Suppurativa
Start date
2021-03-05
Primary completion
2021-07-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.